Neuland Laboratories Limited
NSE: NEULANDLAB · Healthcare
₹22,948.00
+43.00 (+0.19%)
Last close · 30 Aug 2026, 11:53 am IST
- Open
- ₹22,905.00
- Day high
- ₹23,044.00
- Day low
- ₹22,637.00
- Volume
- 37.6 K
- Prev close
- ₹22,905.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 100Nifty Smallcap 250Nifty Smallcap 50
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 23,794 Cr
- Price
- 18,546.00
- P/E (TTM)
- 65.36
- P/E (Fwd)
- 40.77
- P/B
- 12.69
- EV/EBITDA
- 449.65
- EV/Revenue
- 39.65
- PEG
- —
- Div Yield
- 0.18%
- 52W High
- 20,089.00
- 52W Low
- 11,500.00
- Beta
- -0.32
Profitability & income
- Revenue (TTM)
- 606 Cr
- Net Income (TTM)
- 14 Cr
- EBITDA
- 53 Cr
- Gross Margin
- 35.24%
- Op. Margin
- 37.04%
- Net Margin
- 2.29%
- ROE
- 19.42%
- ROA
- 12.42%
- EPS (TTM)
- 283.75
- EPS (Fwd)
- 454.92
Financial health
- Total Debt
- 301 Cr
- Total Cash
- 77 Cr
- Debt/Equity
- 16.07
- Current Ratio
- 1.42
- Quick Ratio
- 0.68
- Book Value
- 1,461.02
- Free Cash Flow
- -50 Cr
- Op. Cash Flow
- 347 Cr
Growth
- Revenue Growth
- 136.40%
- Earnings Growth
- 664.40%
- Earnings QoQ
- 664.80%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 776 Cr | 213 Cr | 320 Cr | 282 Cr | 455 Cr | — | 301 Cr | 1,874 Cr |
| 2025-12-31 | 440 Cr | 41 Cr | 85 Cr | 53 Cr | 196 Cr | — | — | — |
| 2025-09-30 | 514 Cr | 97 Cr | 157 Cr | 133 Cr | 285 Cr | — | 265 Cr | 1,620 Cr |
| 2025-06-30 | 293 Cr | 14 Cr | 42 Cr | 14 Cr | 140 Cr | — | — | — |
| 2025-03-31 | 328 Cr | 28 Cr | 59 Cr | 34 Cr | 156 Cr | — | 157 Cr | 1,525 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,932 Cr | 364 Cr | 599 Cr | 490 Cr | 985 Cr | 347 Cr | 301 Cr | 1,874 Cr |
| 2025-03-31 | 1,434 Cr | 260 Cr | 418 Cr | 267 Cr | 684 Cr | 317 Cr | 157 Cr | 1,525 Cr |
| 2024-03-31 | 1,516 Cr | 300 Cr | 472 Cr | 407 Cr | 782 Cr | 261 Cr | 95 Cr | 1,283 Cr |
| 2023-03-31 | 1,161 Cr | 164 Cr | 279 Cr | 234 Cr | 547 Cr | 237 Cr | 128 Cr | 994 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for NEULANDLAB?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in